Interestingly, a compelling study revealed a positive correlation between ABCC1 and MYCN in neuroblastoma patients exhibiting MYCN amplification as well as in neuroblastoma cells engineered to overexpress the protein [28]. This evidence concerns the gene ABCC1 and neuroblastoma.